Dec 4, 2022

Kelly Knupp, MD, Elected to American Epilepsy Society Board of Directors

View More Press Releases

Press Release

NASHVILLE, Tenn. ― Kelly Knupp, M.D., has been elected to the American Epilepsy Society (AES) board of directors beginning at the conclusion of the Society's annual meeting in Nashville, Dec. 2-6, 2022. A medical and scientific society of more than 4,700 members, the AES is dedicated to advancing research and education for preventing, treating, and curing epilepsy.

Kelly Knupp, M.D., is an associate professor of pediatrics and neurology at the University of Colorado, Aurora. She received her medical degree from the University of New Mexico - School of Medicine, Albuquerque, completed her residency in pediatrics at Children’s Hospital of New York followed by pediatric neurology residency at Columbia University at Children’s Hospital of New York. After her residency, she trained as a clinical fellow in pediatric epilepsy at the Columbia Comprehensive Epilepsy Center at New York Presbyterian Hospital.

Dr. Knupp now practices at Children’s Hospital Colorado in Aurora and is the associate research director of the Neuroscience Institute and director of the Dravet Program and co-interim section chief. Her interests are epileptic encephalopathies including Dravet Syndrome and infantile spasms. She was a founding member of the Pediatric Epilepsy Research Consortium and continues on the steering committee. This group focuses on developing collaborative research across the country for children with epileptic encephalopathies. She also serves on the medical advisory boards of the Epilepsy Foundation of Colorado and the Dravet Syndrome Foundation and the scientific advisory council of Cure Epilepsy.


Davis Renzelmann
Public Communications Inc.

About the American Epilepsy Society

Founded in 1936, the American Epilepsy Society (AES) is a medical and scientific society whose members are dedicated to advancing research and education for preventing, treating and curing epilepsy. AES is an inclusive global forum where professionals from academia, private practice, not-for-profit, government and industry can learn, share and grow to eradicate epilepsy and its consequences.